DNA Methylation in the Diagnosis of Monogenic Diseases
Open Access
- 25 March 2020
- Vol. 11 (4), 355
- https://doi.org/10.3390/genes11040355
Abstract
DNA methylation in the human genome is largely programmed and shaped by transcription factor binding and interaction between DNA methyltransferases and histone marks during gamete and embryo development. Normal methylation profiles can be modified at single or multiple loci, more frequently as consequences of genetic variants acting in cis or in trans, or in some cases stochastically or through interaction with environmental factors. For many developmental disorders, specific methylation patterns or signatures can be detected in blood DNA. The recent use of high-throughput assays investigating the whole genome has largely increased the number of diseases for which DNA methylation analysis provides information for their diagnosis. Here, we review the methylation abnormalities that have been associated with mono/oligogenic diseases, their relationship with genotype and phenotype and relevance for diagnosis, as well as the limitations in their use and interpretation of results.This publication has 167 references indexed in Scilit:
- Digenic inheritance of an SMCHD1 mutation and an FSHD-permissive D4Z4 allele causes facioscapulohumeral muscular dystrophy type 2Nature Genetics, 2012
- In Embryonic Stem Cells, ZFP57/KAP1 Recognize a Methylated Hexanucleotide to Affect Chromatin and DNA Methylation of Imprinting Control RegionsMolecular Cell, 2011
- Risk of colorectal and endometrial cancers in EPCAM deletion-positive Lynch syndrome: a cohort studyThe Lancet Oncology, 2011
- Methylation analysis of 79 patients with growth restriction reveals novel patterns of methylation change at imprinted lociEuropean Journal of Human Genetics, 2010
- The N-terminus of histone H3 is required for de novo DNA methylation in chromatinProceedings of the National Academy of Sciences of the United States of America, 2009
- Hypomethylation at multiple maternally methylated imprinted regions including PLAGL1 and GNAS loci in Beckwith–Wiedemann syndromeEuropean Journal of Human Genetics, 2008
- A Maternal-Zygotic Effect Gene, Zfp57, Maintains Both Maternal and Paternal ImprintsDevelopmental Cell, 2008
- Angelman syndrome 2005: Updated consensus for diagnostic criteriaAmerican Journal of Medical Genetics Part A, 2006
- Epimutation of the TNDM locus and the Beckwith–Wiedemann syndrome centromeric locus in individuals with transient neonatal diabetes mellitusHuman Genetics, 2006
- Identification of a gene (FMR-1) containing a CGG repeat coincident with a breakpoint cluster region exhibiting length variation in fragile X syndromeCell, 1991